Bal Pharma (NSE:BALPHARMA) Margin of Safety % (DCF Dividends Based): N/A (As of Sep. 10, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:BALPHARMA Bal Pharma Ltd NSE:BALPHARMA
66 GF Score
Price ₹114.45
GF Value ₹103.43
Valuation Modestly Overvalued
! 8 Warning Signs
View Full Analysis

What is Bal Pharma Margin of Safety % (DCF Dividends Based)?

Margin of Safety % (DCF Dividends Based) = (Intrinsic Value: DCF (Dividends Based) - Current Price) / Intrinsic Value: DCF (Dividends Based).

Note: Discounted Dividend model is only suitable for companies who have a consistant distribution history with more than 5 years. If the company's dividends does not remain steady over a long period, results may not be accurate due to the low consistency. The model is also only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, the data will not be stored into our database.

Bal Pharma's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Dividends Based) is not calculated.

NSE:BALPHARMA vs ZTS: Margin of Safety % (DCF Dividends Based) Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Bal Pharma's Margin of Safety % (DCF Dividends Based), along with its competitors' market caps and Margin of Safety % (DCF Dividends Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Bal Pharma Margin of Safety % (DCF Dividends Based) vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Bal Pharma's Margin of Safety % (DCF Dividends Based) distribution charts can be found below:

* The bar in red indicates where Bal Pharma's Margin of Safety % (DCF Dividends Based) falls into.


NSE:BALPHARMA
66GF Score
Bal Pharma Ltd NSE:BALPHARMA
Margin of Safety % (DCF Dividends Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bal Pharma (NSE:BALPHARMA) Overvalued in 2026?

Based on GuruFocus' analysis, Bal Pharma stock appears to be overvalued. The current stock price of ₹114.45 is trading 10.7% above its estimated GF Value™ of ₹103.43. GuruFocus considers Bal Pharma to be Modestly Overvalued.

Key valuation signals for NSE:BALPHARMA:

  • Margin of Safety % (DCF Dividends Based): N/A
  • GF Value™: ₹103.43 vs. price of ₹114.45 (10.7% above fair value)
  • GF Score™: 66/100 with 8 warning signs

No single metric tells the full story. See the NSE:BALPHARMA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bal Pharma Business Description

Other Exchanges 524824:India
Address 10/1, Palace Road, 5th Floor, Lakshmi Narayan Complex, Bengaluru, KA, IND, 560052
Bal Pharma Ltd is a pharmaceutical company. It is principally engaged in the manufacturing and marketing of pharmaceutical formulations and active pharmaceutical ingredients. The company specializes in prescription drugs, generic and over-the-counter products, intravenous infusion, and bulk actives.
66GF Score

Get the complete analysis for NSE:BALPHARMA

Margin of Safety % (DCF Dividends Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹114.45
Price
₹103.43
GF Value